1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Demir A, Ursavaş A, Tana Aslan A, Gülbay B, Çiftçi B, Çuhadaroğlu Ç, Keyf F, Fırat H, Yılmaz M, Gerek M, Köktürk O, İtil O, Karakoç Ö, Kaçmaz Başoğlu Ö, Ersu R, Ardıç S, Öktem S, Fırat Güven S, Ulukavak Çiftçi T. Türk Toraks Derneği Obstrüktif uyku apne sendromu tanı ve tedavi uzlaşı raporu. Turkish Thoracic Journal. 2012;13(Suppl 1):1-73.
3. Ortaç Ersoy E, Fırat H, Akaydın S, Özkan Y, Durusu M, Darılmaz Yüce G, Ergün R, Topeli A, Ardıç S. Association of obstructive sleep apnea with homocystein, nitric oxide and total antioxidant capacity levels in patients with or without coronary artery disease. Tuberk Toraks 2014;62:207-14.
4. Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011;6:120-5.
5. Iber C, Ancoli-Israel S, Chesson AL, Quan SF. The AASM manual fort he scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Wetchester, IL 2007:17-59.
6. Fusetti M, Fioretti AB, Valenti M, Masedu F, Lauriello M, Pagliarella M. Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 2012;32:320-5.
7. Kapsimalis F, Varouchakis G, Manousaki A, Daskas S, Nikita D, Kryger M, Gourgoulianis K. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008;186:209-17.
8. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-6.
9. Kallianos A, Trakada G, Papaioannou T, Nikolopouloss I, Mitrakou A, Manios E, Kostopoulos K, Kostopoulos C, Zakopoulos N. Glucose and arterial blood pressure variability in Obstructive Sleep Apnea Syndrome. Eur Rev Med Pharmacol Sci 2013;17:1932-7.
10. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE; Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-30.
11. Drager LF, Jun JC, Polotsky VY. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 2010;24:843-51.
12. Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P, Humeau MP, Bizieux-Thaminy A, Goupil F, Chollet S, Ducluzeau PH, Gagnadoux F; Institut de Recherche en Santé Respiratoire des Pays de la Loire (IRSR) Sleep Cohort Group. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 2013;143:1584-9.
13. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010;17:161-5.
14. Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009;34:243-260.
15. Gasa M, Salord N, Fortuna AM, Mayos M, Vilarrasa N, Dorca J, Montserrat JM, Bonsignore MR, Monasterio C. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J 2011;38:1089-97.
16. Sahebjani H. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest 1998;113:1604-8.
17. Hirotsu C, Tufik S, Guindalini C, Mazzotti DR, Bittencourt LR, Andersen ML. Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample. PLoS One 2013;8:e66891.
18. Ientile R, Curro’ M, Ferlazzo N, Condello S, Caccamo D, Pisani F. Homocysteine, vitamin determinants and neurological diseases. Front Biosci (Schol Ed) 2010;2:359-72.
19. Sariman N, Levent E, Aksungar FB, Soylu AC, Bektaş O. Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome. Respiration 2010;79:38-45.
20. Yavuz Z, Ursavaş A, Ege E, Ozarda Ilçol Y, Karadağ M, Uzaslan E, Gözü RO. [Homocysteine levels in patients with obstructive sleep apnea syndrome]. Tuberk Toraks 2008;56:37-42.
21. Can M, Açikgöz S, Mungan G, Bayraktaroğlu T, Koçak E, Güven B, Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-7.
22. Lavie L, Perelman A, Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 2001;120:900-8.
23. Ozkan Y, Firat H, Simşek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008:12;149-54.
24. Cerbo RM, Cabano R, Lombardi G, Bollani L, Colombo R, Stronati M. From apneic spells to the development of hypertensive hydrocephalus: a case report of homocystinuria with early onset. J Child Neurol 2010:25;368-70.
25. Wang L, Li J, Xie Y, Zhang XG. Association between serum homocysteine and oxidative stress in elderly patients with obstructive sleep apnea/hypopnea syndrome. Biomed Environ Sci 2010;23:42-7.
26. Ramos AM, Pellanda LC, Gus I, Portal VL. Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol 2009;92:227-34.
27. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007;62:509-14.
28. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 2005;46:801-9.
29. Varol E, Ozturk O, Gonca T, Has M, Ozaydin M, Erdogan D, Akkaya A. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010;70:497-502.